Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Levofloxacin-Based Sequential Therapy Compared With Bismuth-Based Quadruple Therapy for Eradication of Helicobacter Pylori Infection: A Randomized Controlled Trial

NCT07574983 is registered in ClinicalTrials.gov with University of Health Sciences Lahore as lead sponsor.

NCT NCT07574983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07574983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Levofloxacin-Based Sequential Therapy Compared With Bismuth-Based Quadruple Therapy for Eradication of Helicobacter Pylori Infection: A Randomized Controlled Trial
Lead sponsor
University of Health Sciences Lahore
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
December 30, 2026
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infections